|
RRP15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.053400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.652000E-01 |
| Normal-vs-Stage2 |
1.175630E-01 |
| Normal-vs-Stage3 |
7.451600E-01 |
| Normal-vs-Stage4 |
4.673800E-01 |
| Stage1-vs-Stage2 |
4.429400E-01 |
| Stage1-vs-Stage3 |
3.580800E-01 |
| Stage1-vs-Stage4 |
2.934400E-01 |
| Stage2-vs-Stage3 |
1.921800E-01 |
| Stage2-vs-Stage4 |
1.886970E-01 |
| Stage3-vs-Stage4 |
6.072400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.777000E-01 |
| Normal-vs-AfricanAmerican |
4.317600E-01 |
| Normal-vs-Asian |
2.779200E-01 |
| Caucasian-vs-AfricanAmerican |
9.386000E-01 |
| Caucasian-vs-Asian |
7.666800E-01 |
| AfricanAmerican-vs-Asian |
7.007800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.659800E-02 |
| Normal-vs-Female |
3.781400E-01 |
| Male-vs-Female |
3.029800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.474000E-01 |
| Normal-vs-Extreme_Weight |
1.015360E-01 |
| Normal-vs-Obese |
9.186800E-01 |
| Normal-vs-Extreme_Obese |
1.220020E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.785800E-01 |
| Normal_Weight-vs-Obese |
6.215200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.437200E-01 |
| Extreme_Weight-vs-Obese |
1.598050E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.125800E-01 |
| Obese-vs-Extreme_Obese |
2.124000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.555190E-01 |
| Normal-vs-Age(41-60Yrs) |
7.040000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.972200E-02 |
| Normal-vs-Age(81-100Yrs) |
4.735800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.408400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.717800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.515100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.055650E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.071970E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.976200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.164200E-01 |
| Normal-VS-Type2 PRCC |
9.863700E-02 |
| Normal-VS-KIRP CIMP |
3.567800E-01 |
| Normal-VS-Unclassified PRCC |
5.484600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.713800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.641600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.919400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.342100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.101600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.782200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.866040E-02 |
| Normal-vs-N1 |
1.485790E-01 |
| Normal-vs-N2 |
7.788600E-01 |
| N0-vs-N1 |
1.787710E-02 |
| N0-vs-N2 |
3.037000E-01 |
| N1-vs-N2 |
6.659200E-01 |
|
|
